| Literature DB >> 24731888 |
C S Pramesh1, Rajendra A Badwe2, Bibhuti B Borthakur3, Madhu Chandra4, Elluswami Hemanth Raj5, T Kannan6, Ashok Kalwar7, Sanjay Kapoor8, Hemant Malhotra9, Sukdev Nayak10, Goura K Rath11, T G Sagar5, Paul Sebastian12, Rajiv Sarin2, V Shanta5, Suresh C Sharma13, Shilin Shukla14, Manavalan Vijayakumar15, D K Vijaykumar16, Ajay Aggarwal17, Arnie Purushotham18, Richard Sullivan18.
Abstract
The delivery of affordable and equitable cancer care is one of India's greatest public health challenges. Public expenditure on cancer in India remains below US$10 per person (compared with more than US$100 per person in high-income countries), and overall public expenditure on health care is still only slightly above 1% of gross domestic product. Out-of-pocket payments, which account for more than three-quarters of cancer expenditures in India, are one of the greatest threats to patients and families, and a cancer diagnosis is increasingly responsible for catastrophic expenditures that negatively affect not only the patient but also the welfare and education of several generations of their family. We explore the complex nature of cancer care systems across India, from state to government levels, and address the crucial issues of infrastructure, manpower shortages, and the pressing need to develop cross-state solutions to prevention and early detection of cancer, in addition to governance of the largely unregulated private sector and the cost of new technologies and drugs. We discuss the role of public insurance schemes, the need to develop new political mandates and authority to set priorities, the necessity to greatly improve the quality of care, and the drive to understand and deliver cost-effective cancer care programmes.Entities:
Mesh:
Year: 2014 PMID: 24731888 DOI: 10.1016/S1470-2045(14)70117-2
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316